Richard Condon, CEO Aspire Pharma, discusses successful leadership ...

The great NHS prescribing lottery. Imagine a patient in Manchester receiving a cutting-edge medication, while another in ...

As Europe’s adoption of the IDMP data model advances, EMA’s centralised Product Management Services (PMS) platform is coming ...

The recent landmark ruling by the UK’s Supreme Court – that the term “sex” in the Equality Act 2010 refers to biological sex, ...

Over the past two decades, clinical trials have undergone significant transformation. Historically, trials followed a ...

In a sector defined by innovation, evidence and outcomes, the true catalyst for transformation is often overlooked: ...

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending mirikizumab (Omvoh) ...

Emerging evidence reveals a clinically significant rebound effect following the discontinuation of glucagon-like peptide-1 ...

The National Institute for Health and Care Excellence (NICE) has published updated guidance recommending Forxiga ...

Global biopharma Eli Lilly will acquire SiteOne Therapeutics, a biotech dedicated to the development of non-opioid medicines ...

The alliance combines Lumanity’s commercial and development strategy capabilities with PICI’s translational research ...

What else is there to share? As it happens, quite a lot. Last time I spoke about the diagnosis of Young Onset Parkinson’s disease (YOPD), how this presented several day-to-day challenges from securing ...